Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
HRMY: Harmony Biosciences Holdings, Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
HRMY
The Story
HRMY
Loading chart data...
Current State
Balance holding
The verdict
Good business
Strong
Revenue growth
+22.8% / yr
Operating margin
21.1%
ROIC
12.5%
Financially safe
Strong
Debt / equity
0.23×
Interest coverage
13.5×
Current ratio
3.58×
Valuation
Unrated
P/E ratio
14.0×
Harmony Biosciences Holdings, Inc.
HRMY
NASDAQ Global Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Harmony Biosciences Holdings, Inc.
HRMY
NASDAQ
·
USD
·
Closed
$35.24
−1.73%
$35.24
−$0.62 (1.73%)
52W Range
63th
pctl
Volume
0.71×
avg
Mkt Cap
2.04B
USD
P/E
14.0
TTM
Div Yield
–
ann
52W Range
63th
pctl
Volume
0.71×
avg
Market Cap
2.04B
USD
P/E Ratio
14.0
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings